Literature DB >> 23775932

Retinal nerve fiber layer thickness and visual hallucinations in Parkinson's Disease.

Jee-Young Lee1, Jae Min Kim, Jeeyun Ahn, Han-Joon Kim, Beom S Jeon, Tae Wan Kim.   

Abstract

Defective visual information processing from both central and peripheral pathways is one of the suggested mechanisms of visual hallucination in Parkinson's disease (PD). To investigate the role of retinal thinning for visual hallucination in PD, we conducted a case-control study using spectral domain optical coherence tomography. We examined a representative sample of 61 patients with PD and 30 healthy controls who had no history of ophthalmic diseases. General ophthalmologic examinations and optical coherence tomography scans were performed in each participant. Total macular thickness and the thickness of each retinal layer on horizontal scans through the fovea were compared between the groups. In a comparison between patients with PD and healthy controls, there was significant parafoveal inner nuclear layer thinning, whereas other retinal layers, including the retinal nerve fiber layer, as well as total macular thicknesses were not different. In terms of visual hallucinations among the PD subgroups, only retinal nerve fiber layer thickness differed significantly, whereas total macular thickness and the thickness of other retinal layers did not differ. The retinal nerve fiber layer was thinnest in the group that had hallucinations without dementia, followed by the group that had hallucinations with dementia, and the group that had no hallucinations and no dementia. General ophthalmologic examinations did not reveal any significant correlation with hallucinations. There were no significant correlations between retinal thicknesses and duration or severity of PD and medication dosages. The results indicate that retinal nerve fiber layer thinning may be related to visual hallucination in nondemented patients with PD. Replication studies as well as further studies to elucidate the mechanism of thinning are warranted.
Copyright © 2013 Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; optical computed tomography; retina thickness; visual hallucination

Mesh:

Year:  2013        PMID: 23775932     DOI: 10.1002/mds.25543

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  32 in total

1.  Progressive retinal structure abnormalities in multiple system atrophy.

Authors:  Carlos E Mendoza-Santiesteban; Jose-Alberto Palma; Jose Martinez; Lucy Norcliffe-Kaufmann; Thomas R Hedges; Horacio Kaufmann
Journal:  Mov Disord       Date:  2015-09-11       Impact factor: 10.338

2.  Retinal thinning correlates with clinical severity in multiple system atrophy.

Authors:  Jeeyun Ahn; Jee-Young Lee; Tae Wan Kim
Journal:  J Neurol       Date:  2016-07-14       Impact factor: 4.849

3.  Imagine that: elevated sensory strength of mental imagery in individuals with Parkinson's disease and visual hallucinations.

Authors:  James M Shine; Rebecca Keogh; Claire O'Callaghan; Alana J Muller; Simon J G Lewis; Joel Pearson
Journal:  Proc Biol Sci       Date:  2015-01-07       Impact factor: 5.349

Review 4.  Trans-synaptic Retrograde Degeneration in the Human Visual System: Slow, Silent, and Real.

Authors:  Marc Dinkin
Journal:  Curr Neurol Neurosci Rep       Date:  2017-02       Impact factor: 5.081

Review 5.  Evidence for the use of pimavanserin in the treatment of Parkinson's disease psychosis.

Authors:  Harini Sarva; Claire Henchcliffe
Journal:  Ther Adv Neurol Disord       Date:  2016-10-03       Impact factor: 6.570

6.  Diplopia in Parkinson's disease: visual illusion or oculomotor impairment?

Authors:  Femke Visser; Annemarie M M Vlaar; Carlijn D J M Borm; Valentin Apostolov; Y X Lee; Irene C Notting; Henry C Weinstein; Henk W Berendse
Journal:  J Neurol       Date:  2019-06-18       Impact factor: 4.849

7.  Correlations among multifocal electroretinography and optical coherence tomography findings in patients with Parkinson's disease.

Authors:  Metin Unlu; Duygu Gulmez Sevim; Murat Gultekin; Cagatay Karaca
Journal:  Neurol Sci       Date:  2018-01-18       Impact factor: 3.307

Review 8.  Psychosis in Parkinson's Disease: Epidemiology, Pathophysiology, and Management.

Authors:  Anna Chang; Susan H Fox
Journal:  Drugs       Date:  2016-07       Impact factor: 9.546

9.  Polymorphisms of DRD2 and DRD3 genes and Parkinson's disease: A meta-analysis.

Authors:  Dongjun Dai; Yunliang Wang; Lingyan Wang; Jinfeng Li; Qingqing Ma; Jianmin Tao; Xingyu Zhou; Hanlin Zhou; Yi Jiang; Guanghui Pan; Limin Xu; Ping Ru; Danfeng Lin; Jun Pan; Leiting Xu; Meng Ye; Shiwei Duan
Journal:  Biomed Rep       Date:  2014-01-13

Review 10.  The psychosis spectrum in Parkinson disease.

Authors:  Dominic H Ffytche; Byron Creese; Marios Politis; K Ray Chaudhuri; Daniel Weintraub; Clive Ballard; Dag Aarsland
Journal:  Nat Rev Neurol       Date:  2017-01-20       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.